Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

BACKGROUND AND AIM: This study aimed to elucidate whether interferon (IFN)-free direct-acting antiviral (DAA) therapy for hepatitis C after curative treatment of hepatocellular carcinoma (HCC) promotes HCC recurrence in a real-world large-scale cohort. METHODS: This multicenter study was conducted b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Mashiba, Toshie, Joko, Kouji, Kurosaki, Masayuki, Ochi, Hironori, Osaki, Yukio, Kojima, Yuji, Nakata, Ryo, Goto, Tohru, Takehiro, Akahane, Kimura, Hiroyuki, Mitsuda, Akeri, Kawanami, Chiharu, Uchida, Yasushi, Ogawa, Chikara, Kusakabe, Atsunori, Narita, Ryuichi, Ide, Yasushi, Abe, Takehiko, Tsuji, Keiji, Kitamura, Tadashi, Okada, Kazuhiko, Sohda, Tetsuro, Shigeno, Masaya, Satou, Takashi, Izumi, Namiki
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5901785/
https://ncbi.nlm.nih.gov/pubmed/29659591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194704
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados